VIVUS, Inc. (VVUS) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies left to report, and VIVUS, Inc.
Arena Pharmaceuticals Inc (ARNA)
Market is closed
News
- First
- << Previous
- 161 - 169
Hot Off the Press: VIVUS, Inc. (VVUS)'s Appeal for EU Approval Denied
Days after launching its obesity drug Qsymia in the U.S. last September, VIVUS, Inc.
What Is It With Arena Pharmaceuticals, Inc. (ARNA) and the EMA?
Regardless of FDA approval, safety issues have been a great concern with regulators and medical practitioners when it comes to obesity drugs.
The FDA Made Biotech Investing Harder (But More Lucrative): Johnson & Johnson (JNJ)
For instance, it's hard to make money on shoo-in Food and Drug Administration approvals. The approval is already reflected in the price.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Will There Ever Be an Obesity Drug Blockbuster?
Investors are anxiously waiting for the launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai's obesity drug Belviq, which will match up with VIVUS, Inc.
VIVUS, Inc. (VVUS): This Obesity Bet Just Became More Attractive
The importance of an FDA drug approval cannot be denied, but it is also a fact that the event can have different effects on the stock price.
Sanofi SA (SNY) & ISIS Pharmaceuticals, Inc. (ISIS) Out-Limbo Aegerion Pharmaceuticals, Inc. (AEGR) in HoFH
I was admittedly never very good when it came to limbo because I'm not very flexible and I'm all legs. Sanofi SA (ADR) (NYSE:SNY) and ISIS Pharmaceuticals, Inc.
2 Growth Catalysts Could Push Arena Pharmaceuticals, Inc. (ARNA) Higher In 2013
An advisory committee to the European Medicines Agency has asked for more information on heart valve issues, psychiatric side effects, and tumors that were detected during studies on rats.
Why Arena Pharmaceuticals, Inc. (ARNA) Shares Lost Weight
What: Shares of fat-fighting pharmaceutical company Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shed as much as 11% after the European equivalent to the U.S.
- First
- << Previous
- 161 - 169
Billionaire Hedge Funds
